Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Honore, T. et al. (1988) Science 241, 701.
- Long, S.K. et al. (1990) Br. J. Pharmacol. 100, 850.
- Alomone Labs CNQX inhibits GluA1 channels expressed in Xenopus oocytes.Time course of current reversible inhibition by 50 and 500 μM CNQX (#C-140) (at 0 mV) in the presence of 10 μM glutamate. Amplitude change as a result of the application of raising concentrations of CNQX (perfusion duration indicated by the horizontal bar, concentration as indicated).
- Honore, T. et al. (1988) Science 241, 701.
- Traynelis, S.F. et al. (2010) Pharmacol. Rev. 62, 405.
- Long, S.K. et al. (1990) Br. J. Pharmacol. 100, 850.
- Watkins, J.C. et al. (1990) Trends Pharmacol. Sci. 11, 25.
The first widely used competitive AMPA receptor antagonists were quinoxalinediones (CNQX, DNQX, NBQX), which were highly selective over NMDA receptors but antagonized kainate receptors. CNQX is a potent, competitive AMPA/kainate receptor antagonist. It also acts as an antagonist at the NMDA receptor glycine site.
This non-NMDA receptor antagonist inhibits [3H]AMPA binding to quisqualate receptors at submicromolar concentrations. CNQX also selectively blocks the excitatory action of quisqualate and kainate on spinal neurons with little or no effect on that of NMDA.
The concentrations that inhibit 50% of [3H]AMPA binding (IC50) for CNQX in dorsal horn neurons is 300 nM1.
The association of AMPA receptors with TARP auxiliary subunits converts CNQX from an antagonist to a weak partial agonist. CNQX induces partial domain closure, consistent with the activity of a partial agonist. CNQX blocks both fast AMPA-mediated and slow kainate receptor-mediated mEPSCs2.
EC50 values for depression of the monosynaptic ventral root reflex is 1.0 ± 0.3 µM3.
Direct binding studies using CNQX as a radioligand show that CNQX binds with high affinity (40 nM) to both high (14 nM) and low (235 nM) affinity AMPA binding sites in rat brain4.
CNQX (#C-140) is a highly pure, synthetic, and biologically active compound.
Applications
Citations
- Mouse brain slices (whole cell recording).
Inbar, K. et al. (2020) J. Neurosci. 40, 1321.
- Babiec, W.E. et al. (2017) J. Neurosci. 37, 1950.
- Pollak, J. et al. (2017) PLoS ONE 12, e0172884.
Specifications
Scientific Background
Related Products
Antibodies
- Anti-GluR1 (GluA1) (extracellular) Antibody (#AGC-004)
- Anti-GluR2 (GluA2) (extracellular) Antibody (#AGC-005)
- Anti-GluR3 (GluA3) (extracellular) Antibody (#AGC-010)
- Anti-GluR4 (GluA4) (extracellular) Antibody (#AGC-019)
- Anti-Stargazin Antibody (#ACC-012)
- Anti-CACNG3 Antibody (#ACC-113)
- Anti-GRIK1 (GluK1) (extracellular) Antibody (#AGC-008)
- Anti-GRIK2 (GluK2) Antibody (#AGC-009)
- Anti-GRIK3 (GluK3) (extracellular) Antibody (#AGC-040)
- Anti-GRIK4 (KA1) (extracellular) Antibody (#AGC-041)
- Anti-GRIK5 (GluK5) (extracellular) Antibody (#AGC-042)
Pharmacological tools
Explorer kits & Research packs
- AMPA Receptor Antibody Explorer Kit (#AK-213)
- Kainate Receptor Antibody Explorer Kit (#AK-555)
- AMPA Receptor Antagonist Explorer Kit (#EK-210)
- AMPA Receptor Modulator Explorer Kit (#EK-211)
- Classical Ion Channel Blockers for Pain Research Explorer Kit (#EK-355)
- GluR1 (GluA1) Overexpressed Membrane Fractions (#LX-103)
- GluR1 (GluA1) Antibody and Membrane Fractions Kit (#LK-103)
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us